Cemex S.A.B. De C.V. ADR (NYSE: CX) Has Another Chance To Impress You

Principal Global Investors LLC recently announced the acquisition of new stake in Cemex S.A.B. De C.V. ADR (NYSE:CX). The institutional investor has increased its shareholding in the Basic Materials company by 0.32% to 19.31 million shares with purchase of 61954.0 shares. This fresh investment now brings its stake to 1.28% valued currently at $133.45 million. In addition, Acadian Asset Management LLC raised its holdings by 5.54 million to 18.92 million shares. And American Century Investment Manag has lifted its position by 3.38% or 0.32 million shares – to 9.74 million shares.

Currently, there are 1.51B common shares owned by the public and among those 1.51B shares have been available to trade.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The top 3 mutual fund holders in Cemex S.A.B. De C.V. ADR are American Funds EuroPacific Growth, Fidelity Inv. Trust – Emerging Ma, and Baillie Gifford Emerging Markets. American Funds EuroPacific Growth owns 18.63 million shares of the company’s stock, all valued at over $128.72 million. The company sold -0.15 million shares recently to bring their total holdings to about 1.23% of the shares outstanding. Fidelity Inv. Trust – Emerging Ma sold -8.42 million shares to see its total holdings shrink to 11.88 million shares valued at over $82.1 million and representing 0.79% of the shares outstanding. Baillie Gifford Emerging Markets now owns shares totaling to 0.52% of the shares outstanding.

However, the script later moved the day high at 8.00, up 1.52%. The company’s stock has a 5-day price change of 12.22% and 12.22% over the past three months. CX shares are trading 97.28% year to date (YTD), with the 12-month market performance up to 98.26% higher. It has a 12-month low price of $4.01 and touched a high of $8.46 over the same period. CX has an average intraday trading volume of 6.43 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 12.67%, 19.75%, and 20.24% respectively.

Institutional ownership of Cemex S.A.B. De C.V. ADR (NYSE: CX) shares accounts for 29.58% of the company’s 1.51B shares outstanding. Mutual fund holders own 10.11%, while other institutional holders and individual stakeholders account for 19.47% and — respectively.

It has a market capitalization of $12.08B and a beta (3y monthly) value of 1.48. The stock’s trailing 12-month PE ratio is 25.64, while the earnings-per-share (ttm) stands at $0.31. The company has a PEG of 1.89 and a Quick Ratio of 0.58 with the debt-to-equity ratio at 0.62. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.56% over the week and 3.12% over the month.

Analysts forecast that Cemex S.A.B. De C.V. ADR (CX) will achieve an EPS of $0.17 for the current quarter, $0.16 for the next quarter and $0.8 for 2024. The lowest estimate earnings-per-share for the quarter is $0.05 while analysts give the company a high EPS estimate of $0.35. Comparatively, EPS for the current quarter was -$0.12 a year ago. Earnings per share for the fiscal year are expected to increase by 80.67%, and 22.27% over the next financial year. EPS should grow at an annualized rate of 13.60% over the next five years, compared to -1.42% over the past 5-year period.

Looking at the support for the CX, a number of firms have released research notes about the stock. Citigroup stated their Buy rating for the stock in a research note on November 02, 2023, with the firm’s price target at $8.20.

Most Popular

Related Posts